Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI109219

Binding of Chemotactic Collagen-Derived Peptides to Fibroblasts: THE RELATIONSHIP TO FIBROBLAST CHEMOTAXIS

Thomas M. Chiang, Arnold E. Postlethwaite, Edwin H. Beachey, Jerome M. Seyer, and Andrew H. Kang

Veterans Administration Hospital, Memphis, Tennessee 38104

Department of Biochemistry, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Department of Medicine, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Department of Microbiology, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Find articles by Chiang, T. in: PubMed | Google Scholar

Veterans Administration Hospital, Memphis, Tennessee 38104

Department of Biochemistry, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Department of Medicine, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Department of Microbiology, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Find articles by Postlethwaite, A. in: PubMed | Google Scholar

Veterans Administration Hospital, Memphis, Tennessee 38104

Department of Biochemistry, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Department of Medicine, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Department of Microbiology, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Find articles by Beachey, E. in: PubMed | Google Scholar

Veterans Administration Hospital, Memphis, Tennessee 38104

Department of Biochemistry, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Department of Medicine, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Department of Microbiology, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Find articles by Seyer, J. in: PubMed | Google Scholar

Veterans Administration Hospital, Memphis, Tennessee 38104

Department of Biochemistry, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Department of Medicine, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Department of Microbiology, University of Tennessee Center for the Health Sciences, Memphis, Tennessee 38104

Find articles by Kang, A. in: PubMed | Google Scholar

Published November 1, 1978 - More info

Published in Volume 62, Issue 5 on November 1, 1978
J Clin Invest. 1978;62(5):916–922. https://doi.org/10.1172/JCI109219.
© 1978 The American Society for Clinical Investigation
Published November 1, 1978 - Version history
View PDF
Abstract

We previously showed that collagen, α-chains, and collagen-derived peptide fragments induce chemotactic migration of human fibroblasts in vitro. We now describe biochemical and immunological evidence showing there are binding sites for collagen peptides on fibroblast membranes.

By the use of 14C-labeled α1(I) chain, binding to intact fibroblasts was demonstrated. The process was reversible, and time- and fibroblast concentration-dependent. Scatchard plot analyses of the data obtained for the binding of α1(I) suggested that there are ≅ 16 × 106 binding sites per fibroblast with an association constant of 1.1 × 107/M for α1(I). Dissociation of the bound radioactivity and subsequent chromatographic analysis on agarose A-1.5 m revealed that the α1 was unaltered. The binding of 14C-labeled α1 was inhibited by each of the CNBr peptides derived from α1 chain of chick skin collagen and CNBr peptide mixtures of various genetic types of collagen chains.

Immunofluorescence studies with anti-α1 antibody showed that α1-treated fibroblasts exhibited strong immunofluorescence. The intensity of fluorescence was markedly diminished by prior absorption of the antibody with α1. The α1-treated cells stained with preimmune sera did not show significant fluorescence.

Dose-response curves of fibroblast chemotaxis induced by α1 and the binding of α1 by fibroblasts correlate closely. Furthermore, the potency of α1-CNBr peptides as chemotactic agents correlates with their ability to inhibit the binding of labeled α1(I). These data suggest the hypothesis that collagenderived peptides cause fibroblast chemotactic migration by acting on fibroblast membranes.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 916
page 916
icon of scanned page 917
page 917
icon of scanned page 918
page 918
icon of scanned page 919
page 919
icon of scanned page 920
page 920
icon of scanned page 921
page 921
icon of scanned page 922
page 922
Version history
  • Version 1 (November 1, 1978): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts